Because of a lapse in government funding, the information on this
website may not be up to date, transactions submitted via the
website may not be processed, and the agency may not be able to
respond to inquiries until appropriations are enacted. The NIH
Clinical Center (the research hospital of NIH) is open. For more
details about its operating status, please visit
cc.nih.gov. Updates
regarding government operating status and resumption of normal
operations can be found at
opm.gov.
Leukocyte Adherence Inhibition Test MeSH Descriptor Data 2025
Test for cell-mediated antitumor immunity and related serum blocking factors based on the finding that leukocytes from cancer patients, but not from controls, when mixed in vitro with antigenic extracts of tumors of the same histological type, undergo a diminution in their normal adherence to glass surfaces. Sera from tumor-bearing patients block the LAI reaction of their own leukocytes or those of other patients with the same type of tumor.
Entry Version
LEUKOCYTE ADHERENCE INHIB TEST
Entry Term(s)
LAI Test
NLM Classification #
QW 525.5.L6
Previous Indexing
Immunity, Cellular (1970-1976)
Leukocytes (1966-1976)
Public MeSH Note
91; was see under IMMUNOLOGIC TECHNIQUES 1977-90
History Note
91(77); was see under IMMUNOLOGIC TECHNIQUES 1977-90
Test for cell-mediated antitumor immunity and related serum blocking factors based on the finding that leukocytes from cancer patients, but not from controls, when mixed in vitro with antigenic extracts of tumors of the same histological type, undergo a diminution in their normal adherence to glass surfaces. Sera from tumor-bearing patients block the LAI reaction of their own leukocytes or those of other patients with the same type of tumor.